Sun Grapples With Impact Of Halol FDA Import Alert
US Supplies From Non-Compliant Plant Account For 3% Of Annual Sales
Sun Pharma’s Halol facility has been placed under an import alert by the FDA following an inspection earlier this year that uncovered GMP deficiencies.
